The altered lymphocytes homing in IBD can facilitate the upregulation of MAdCAM-1 and CCL25 expression in the liver and the migration of gut tropic T cells to sites outside of the intestine, contributing to the development of inflammation [6,7]. Here, MADCAM1 is linked to inflammatory bowel disease.